Controlled release matrix tablets of zidovudine: Effect of formulation variables on the in vitro drug release kinetics

AAPS PharmSciTech

Volumn 9, Issue 1, 2008, Pages 302-313

  Ravi, Punna Rao ^a   Kotreka, Udaya Kanth ^a   Saha, Ranendra Narayan ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Controlled release; Matrix tablets; Release kinetics; Zidovudine

Indexed keywords

CARBOMER; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; POLYMER; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DIFFUSION; DRUG STABILITY; DRUG STORAGE; IN VITRO STUDY; MATRIX TABLET; PH; TABLET COMPRESSION; TABLET FRIABILITY; TABLET HARDNESS; TABLET MANUFACTURE; TABLET THICKNESS; CHEMISTRY; COMBINATORIAL CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG FORMULATION; DRUG SCREENING; EVALUATION; KINETICS; MATERIALS TESTING; METHODOLOGY; TABLET;

ANTI-HIV AGENTS; COMBINATORIAL CHEMISTRY TECHNIQUES; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; KINETICS; MATERIALS TESTING; TABLETS; ZIDOVUDINE;

EID: 44849110294     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-007-9030-8     Document Type: Article

References (35)

1. S. F. Anthony, and H. L. Clifford. Human immunodeficiency virus (HIV) disease: AIDS and related disorders. In: E. Braunwald, A. S. Fauci, D. L. Kasper, S. L. Hauser, D. L. Longo, and J. L. Jameson (eds.), Harrison's Principles of Internal Medicine, McGraw-Hill, New York, USA, 2001, pp. 1852-1913.
2. O. L. Laskin, P. de Miranda, and M. R. Blum. Azidothymidine steady-state pharmacokinetics in patients with AIDS and AIDS-related complex. J. Infect. Dis 159 (no. 4): 745-747 (1989).
3. S. Chitnis, D. Mondal, and K. C. Agrawal. Zidovudine (AZT) treatment suppresses granulocyte-monocyte colony stimulating factor receptor type alpha (GM-CSFR alpha) gene expression in murine bone marrow cells. Life Sci 12: 967-978 (2002).
4. P. Chariot, I. Drogou, I. de Lacroix-Szmania, M. C. Eliezer-Vanerot, B. Chazaud, A. Lombes, A. Schaeffer, and E. S. Zafrani. Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. J. Hepatol 30 (no. 1): 156-160 (1999).
5. M. C. Re, I. Bon, P. Monari, R. Gorini, P. Schiavone, D. Gibellini, and M. La Placa. Drug failure during HIV-1 treatment. New perspectives in monitoring drug resistance. New Microbiol 26 (no. 4): 405-413 (2003).
6. Y. W. Chien. Novel drug delivery systems. In Y. W. Chien (ed.), Oral Drug Delivery and Delivery Systems, Marcel Dekker, New York, USA, 1992, pp. 139-196.
7. S. P. Vyas, and R. K. Khar. Controlled drug delivery: Concepts and advances. In S. P. Vyas, and R. K. Khar (eds.), Controlled oral administration, Vallabh Prakashan, Delhi, India, 2002, pp. 155-195.
8. R. K. V. Ranga, D. K. Padmalatha, and B. Buri. Cellulose matrices for zero-order release of soluble drugs. Drug Dev. Ind. Pharm 14: 2299-2320 (1988).
9. I. Zabeed, B. Almas, and A. Muhammad. Controlled release naproxen using micronized ethyl cellulose by wet-granulation and solid-dispersion method. Drug Dev. Ind. Pharm 28 (no. 2):129-134 (2002).
10. M. Riikka, S. Eero, K. Ossi, P. Heli, N. Riku, L. Marko, and K. Jarkko. Controlled release of saccharides from matrix tablets. Eur. J. Pharm. Biopharm 62: 163-170 (2006).
11. A. B. Silvina, C. L. Marcia, and J. S. Claudio. Swellable matrices for the controlled-release of diclofenac sodium. Formulation and in vitro studies. Pharm. Dev. Tech 9 (no. 1): 75-83 (2004).
12. T. A. Manuel, and V. R. Leopoldo. Effect of formulation and process variables on the release behavior of amoxicillin matrix tablets. Drug Dev. Ind. Pharm 30 (no. 8): 901-908 (2004).
13. R. W. Korsenmeyer, and N. A. Peppas. Macromolecular and modeling aspects of swelling-controlled systems. In S. Z. Mansdorf, and T. J. Roseman (eds.), Controlled Release Delivery Systems, Marcel Dekker, New York, USA, 1983, p. 77.
14. B. J. Lee, S. G. Ryu, and J. H. Cui. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin. Drug Dev. Ind. Pharm 25: 493-501 (1999).
15. C. L. Vargas, and E. S. Ghaly. Kinetic release of theophylline from hydrophilic swellable matrices. Drug Dev. Ind. Pharm 25: 1045-1050 (1999).
16. M. V. Velasco, J. L. Ford, P. Rowe, and A. R. Rajabi-Siahboomi. Influence of drug: Hydroxypropyl methylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC matrices. J. Control. Rel 57: 75-85 (1999).
17. C. Sajeev, and R. N. Saha. Formulation and comparative evaluation of controlled release diclofenac tablets prepared by matrix embedding technique, membrane barrier technique and combination of the two. Drug Dev. Res 53 (no. 1): 1-8 (2001).
18. P. Jelena, D. Zorica, J. Milica, and I. Svetlana. An investigation into the factors influencing drug release from hydrophilic matrix tablets based on novel carbomer polymers. Drug Delivery 11: 59-65 (2004).
19. G. S. Rekhi, and S. S. Jambhekar. Ethyl cellulose - a polymer review. Drug Dev. Ind. Pharm 21: 61-77 (1995).
20. P. R. Katikaneni, S. M. Upadrashta, S. H. Neau, and A. K. Mitra. Ethylcellulose matrix controlled release tablets of a water-soluble drug. Int. J. Pharm 123: 119-125 (1995).
21. S. H. Neau, M. A. Howard, J. S. Claudius, and D. R. Howard. The effect of the aqueous solubility of xanthine derivatives on the release mechanism from ethylcellulose matrix tablets. Int. J. Pharm 179: 97-105 (1999).
22. K. Atul, K. T. Ashok, K. J. Narendra, and J. Subheet. Formulation and in vitro, in vivo evaluation of extended-release matrix tablet of zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers. AAPS Pharm. Sci. Tech. 7 (1) (2006) (article 1).
23. H. A. Benghuzzi, R. M. Barbaro, and P. K. Bajpai. In vitro release of azidothymidine (AZT) by ceramic drug delivery systems. Biomed. Sci. Instrum 26: 151-156 (1990).
24. H. A. Benghuzzi. Long-term sustained delivery of 3′-azido-2′,3′-dideoxythymidine in vivo by means of HA and TCP delivery devices. Biomed. Sci. Instrum 36: 343-348 (2000).
25. R. R. Punna, and R. N. Saha. A new rapid, simple and validated UV spectrophotometric method for estimation of zidovudine in bulk, formulations and dissolution samples. AAPS J. 6 (4) (2004) (Abstract T3054).
26. S. Li, Y. Shen, W. Li, and X. Hao. A common profile for polymer-based controlled release and its logical interpretation to general release process. J. Pharm. Pharmaceut. Sci 9: 238-244 (2006).
27. R. L. Ritger, and N. A. Peppas. A simple equation for the description of solute release. II. Fickian and anomalous release from swellable devices. J. Control. Rel 5: 37-42 (1987).
28. P. Costa, and J. M. S. Lobo. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci 13: 123-133 (2001).
29. A. A. S. Araujo, S. Stropirtis, L. P. Mercuri, F. M. S. Carvalho, F. M. dos Santos, and J. R. Matos. Thermal analysis of the antiretroviral Zidovudine (AZT) and evaluation of the compatibility with excipients used in solid dosage forms. Int. J. Pharm 260: 303-314 (2003).
30. J. L. Ford, M. H. Rubunstein, and J. E. Hogan. Propranolol hydrochloride and aminophylline release from matrix tablets containing hydroxypropyl methylcellulose. Int. J. Pharm 24: 339-350 (1985).
31. M. A. Anjali, H. N. Steven, and L. B. Peter. Wet granulation fine particle ethyl cellulose tablets: Effect of production variables and mathematical modeling of drug release. AAPS PharmSci. 5 (2):aRticle 13 (2003).
32. H. Kim, and R. Fassihi. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. J. Pharm. Sci 86 (no. 3): 323-328 (1997).
33. B. P. Marcos, J. L. Ford, D. J. Armstrong, P. N. C. Elliott, C. Rostron, and J. E. Hogan. Influence of pH on the release of propranolol hydrochloride from matrices containing HPMC K4 M and Carbopol 974. J. Pharm. Sci 85 (no. 3): 330-334 (1996).
34. F. Atsuko, F. Ryuta, Y. Yorinobu, and S. Hisakazu. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules III.1) Effects of the dissolution condition on the release process. Chem. Pharm. Bull 54 (no. 8): 1091-1096 (2006).
35. N. R. Maichel, L. S. Roger, and B. S. Joseph. The effect of formulation composition and dissolution parameters on the gel strength of controlled release hydrogel tablets. Pharm. Dev. Tech 6 (no. 4): 583-593 (2001).